Market Overview

The Global Market for Molecular Cytogenetics to 2023: Market Size, Share, Development, Growth, and Demand Forecast -


The "Molecular
Cytogenetics Market by Offering, by Technology, by Application, by End
User, by Geography - Global Market Size, Share, Development, Growth, and
Demand Forecast, 2014 - 2023"
report has been added to's

Global molecular cytogenetics market is forecasted to attain revenue of
$3.3 billion by 2023.

The market is mainly driven by growing implementation of
pharmacogenomics in personalized disease management and drug
development, rising cancer cases, advancements in cytogenetic
techniques, and rise in genetic-based prediction of chromosomal

Based on offering, the molecular cytogenetics market has been
categorized into consumables, software and services and instruments.
Globally, the market for software and services is expected to register
fastest growth, with CAGR of 10.5% during the forecast period. This can
be attributed to rapid adoption of automation in laboratory process and
rising preference for outsourcing of expensive services.

Based on technology, the molecular cytogenetics market has been
categorized into comparative genomic hybridization (CGH), fluorescence
in-situ hybridization (FISH), immunohistochemistry, karyotyping and
others. The karyotyping technology market for molecular cytogenetics is
further categorized into spectral and virtual. In 2017, spectral
karyotyping held larger share, of 66.0%, in molecular cytogenetics
market, owing to the usage of these technique for the detection of
complex chromosomal aberration as well as for identification of new
leukaemia subgroups.

During the forecast period, the molecular cytogenetics market is
expected to witness fastest growth in personalized medicine application,
at a CAGR of 10.1%. This growth is attributable to rise in demand for
precision medicine coupled with high investments in research and

Based on end user, the molecular cytogenetics market has been classified
into clinical and research laboratories, academic research institutes,
hospitals and pathology laboratories and pharmaceutical and
biotechnology companies. Among these, clinical and research laboratories
held the largest share as an end-user category during the historical
period in this market and accounted for a 33.4% share in 2017.

Key Highlights

  • Molecular cytogenetics market to witness fastest growth in
    Asia-Pacific (APAC)
  • Market players are focusing on developing technologically advanced
    molecular cytogenetics products

Key Topics Covered

Chapter 1. Research Background

Chapter 2. Research Methodology

Chapter 3. Executive Summary

Chapter 4. Introduction

Chapter 5. Global Market Size & Forecast

Chapter 6. North America Market Size & Forecast

Chapter 7. Europe Market Size & Forecast

Chapter 8. APAC Market Size & Forecast

Chapter 9. LATAM Market Size & Forecast

Chapter 10. MEA Market Size & Forecast

Chapter 11. Global Strategic Developments

Chapter 12. Company Profiles

  • Abbott Laboratories
  • Danaher Corporation
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann La-Roche AG
  • Agilent Technologies Inc.
  • Perkinelmer Inc.
  • Illumina Inc.
  • Quest Diagnostics Inc.
  • Neogenomics Inc.

For more information about this report visit

View Comments and Join the Discussion!